| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 253,110 | $80 | $19.2M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 43,060 | $130 | $5.5M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 23,140 | $180 | $4.1M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 41,820 | $90 | $3.9M |
| G9002 | Coordinated care fee, maintenance rate | 16,180 | $230 | $3.7M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 15,000 | $80 | $1.2M |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 79,220 | $10 | $475.3K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 22,530 | $10 | $292.8K |
| 99282 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a straightforward level of medical decision making. | 4,780 | $40 | $200.6K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,510 | $40 | $198.2K |